PL253821A1 - Method of obtaining derivatives of 1,4-dihydropyridine - Google Patents
Method of obtaining derivatives of 1,4-dihydropyridineInfo
- Publication number
- PL253821A1 PL253821A1 PL25382185A PL25382185A PL253821A1 PL 253821 A1 PL253821 A1 PL 253821A1 PL 25382185 A PL25382185 A PL 25382185A PL 25382185 A PL25382185 A PL 25382185A PL 253821 A1 PL253821 A1 PL 253821A1
- Authority
- PL
- Poland
- Prior art keywords
- dihydropyridine
- obtaining derivatives
- derivatives
- obtaining
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848414520A GB8414520D0 (en) | 1984-06-07 | 1984-06-07 | Dihydropyridines |
GB858508736A GB8508736D0 (en) | 1985-04-03 | 1985-04-03 | Dihydropyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
PL253821A1 true PL253821A1 (en) | 1986-07-01 |
Family
ID=26287832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL25382185A PL253821A1 (en) | 1984-06-07 | 1985-06-05 | Method of obtaining derivatives of 1,4-dihydropyridine |
Country Status (14)
Country | Link |
---|---|
US (1) | US4618609A (en) |
EP (1) | EP0164247B1 (en) |
JP (1) | JPH0641464B2 (en) |
AU (1) | AU556496B2 (en) |
DE (1) | DE3567460D1 (en) |
DK (1) | DK170402B1 (en) |
ES (1) | ES8700857A1 (en) |
FI (1) | FI852222L (en) |
GR (1) | GR851383B (en) |
HU (1) | HUT41404A (en) |
IE (1) | IE57816B1 (en) |
IL (1) | IL75411A0 (en) |
PL (1) | PL253821A1 (en) |
PT (1) | PT80597B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
EP0233228A1 (en) * | 1985-08-06 | 1987-08-26 | Boehringer Mannheim Italia S.P.A. | Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines |
GB8527698D0 (en) * | 1985-11-09 | 1985-12-11 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
US4761420A (en) * | 1986-06-13 | 1988-08-02 | Laboratoires Syntex S.A. | Antihypertensive dihydropyridine derivatives |
US4920134A (en) * | 1987-08-07 | 1990-04-24 | Takeda Chemical Industries, Ltd. | 2-O-pyrimidinyl glycerol derivatives |
US5691360A (en) * | 1993-12-08 | 1997-11-25 | Alcon Laboratories, Inc. | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
US5424321A (en) * | 1993-12-08 | 1995-06-13 | Alcon Laboratories, Inc. | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
AU2004315596B2 (en) * | 2003-08-29 | 2011-11-24 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis |
WO2010075290A1 (en) * | 2008-12-22 | 2010-07-01 | President And Fellows Of Harvard College | Unsaturated heterocyclic inhibitors of necroptosis |
CA2772760A1 (en) | 2008-12-23 | 2010-07-01 | President And Fellows Of Harvard College | Small molecule inhibitors of necroptosis |
WO2014145022A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
US9944628B2 (en) | 2014-12-11 | 2018-04-17 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis and related methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2951945A1 (en) * | 1979-12-22 | 1981-07-02 | Ibm Deutschland Gmbh, 7000 Stuttgart | CIRCUIT ARRANGEMENT FOR CAPACITIVE READING SIGNAL AMPLIFICATION IN AN INTEGRATED SEMICONDUCTOR STORAGE WITH AN INTEGRATED SEMICONDUCTOR STORAGE WITH STORAGE CELLS IN MTL TECHNOLOGY |
ATE20064T1 (en) * | 1982-07-22 | 1986-06-15 | Pfizer | ANTI-ISCHEMIC AND ANTI-HYPERTENSIVE DIHYDROPYRIDIN DERIVATIVES. |
PT77842B (en) * | 1982-12-21 | 1986-05-05 | Pfizer | Process for preparing dihydropyridines |
US4515799A (en) * | 1983-02-02 | 1985-05-07 | Pfizer Inc. | Dihydropyridine anti-ischaemic and antihypertensive agents |
-
1985
- 1985-05-29 EP EP85303765A patent/EP0164247B1/en not_active Expired
- 1985-05-29 DE DE8585303765T patent/DE3567460D1/en not_active Expired
- 1985-05-31 JP JP60118702A patent/JPH0641464B2/en not_active Expired - Lifetime
- 1985-06-03 FI FI852222A patent/FI852222L/en not_active Application Discontinuation
- 1985-06-05 US US06/741,339 patent/US4618609A/en not_active Expired - Lifetime
- 1985-06-05 IL IL75411A patent/IL75411A0/en unknown
- 1985-06-05 PT PT80597A patent/PT80597B/en not_active IP Right Cessation
- 1985-06-05 PL PL25382185A patent/PL253821A1/en unknown
- 1985-06-06 AU AU43349/85A patent/AU556496B2/en not_active Ceased
- 1985-06-06 GR GR851383A patent/GR851383B/el unknown
- 1985-06-06 DK DK253785A patent/DK170402B1/en not_active IP Right Cessation
- 1985-06-06 IE IE1417/85A patent/IE57816B1/en unknown
- 1985-06-06 HU HU852246A patent/HUT41404A/en unknown
- 1985-06-07 ES ES543999A patent/ES8700857A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PT80597A (en) | 1985-07-01 |
FI852222A0 (en) | 1985-06-03 |
ES8700857A1 (en) | 1986-11-16 |
AU556496B2 (en) | 1986-11-06 |
DK253785A (en) | 1985-12-08 |
ES543999A0 (en) | 1986-11-16 |
IL75411A0 (en) | 1985-10-31 |
DE3567460D1 (en) | 1989-02-16 |
HUT41404A (en) | 1987-04-28 |
IE851417L (en) | 1985-12-07 |
DK253785D0 (en) | 1985-06-06 |
PT80597B (en) | 1987-04-23 |
EP0164247B1 (en) | 1989-01-11 |
FI852222L (en) | 1985-12-08 |
IE57816B1 (en) | 1993-04-21 |
GR851383B (en) | 1985-11-25 |
US4618609A (en) | 1986-10-21 |
EP0164247A1 (en) | 1985-12-11 |
JPS611685A (en) | 1986-01-07 |
DK170402B1 (en) | 1995-08-21 |
AU4334985A (en) | 1985-12-12 |
JPH0641464B2 (en) | 1994-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL256983A1 (en) | Method of obtaining novel derivatives of cyclohexanodione-1,3 | |
PL256985A1 (en) | Method of obtaining novel derivatives of cyclohexanodione-1,3 | |
PL254207A1 (en) | Method of obtaining derivatives of ganglyosides | |
PL253108A1 (en) | Method of obtaining novel derivatives of 1,4-dihydronaphtidrine and their salts | |
PL251972A1 (en) | Method of obtaining derivatives of pleuromutiline | |
PL252773A1 (en) | Method of obtaining novel derivatives of 1,4-dihydropyridine | |
PL256984A1 (en) | Method of obtaining novel derivatives of cyclohexanodione-1,3 | |
GB8515413D0 (en) | 1 4-dihydropyridine derivatives | |
BG43865A3 (en) | Method for preparing of 1, 3- disubstituted 2- oxyindols | |
PL268618A1 (en) | The method of manufacture of 1,4-dihydropyridine derivatives | |
PL253821A1 (en) | Method of obtaining derivatives of 1,4-dihydropyridine | |
PL253820A1 (en) | Method of obtaining derivatives of 1,4-dihydropyridine | |
PL264492A1 (en) | Method of obtaining 1,2,4,-triazolcarbaminates | |
PL251584A1 (en) | Method of obtaining novel derivatives of 1,4-dihydropyridine | |
PL255723A1 (en) | Method of obtaining derivatives of 1,6-phenoxyprostatrienic acid | |
PL253089A1 (en) | Method of obtaining novel derivatives of iminotriazolidine | |
PL267418A1 (en) | Method of obtaining derivatives of 2,3-dihydrofurene | |
PL257668A1 (en) | Method of obtaining novel derivatives of 4,4-dialkylazethydinone | |
PL251456A1 (en) | Method of obtaining derivatives of thioxantene | |
PL255399A1 (en) | Method of obtaining 1,3-diacyl-2-ketoindoles | |
PL256694A1 (en) | Method of obtaining derivatives of 1,4-dihydropyridine | |
PL266240A1 (en) | Method of obtaining derivatives of 1,3,2-oxazaphosphorinate | |
PL257530A1 (en) | Method of obtaining novel derivatives of 1,4-dihydropyridine | |
PL271920A1 (en) | Method for manufacturing new derivatives of 1,4 - dihydropyridine | |
PL250146A1 (en) | Method of obtaining derivatives of 1,2-dithiolate |